Skip to content
2000
Volume 23, Issue 12
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Obsessive-compulsive disorder is a common neuropsychiatric disorder that markedly affects the quality of life of affected patients. There is increasing evidence that abnormal epigenetic mechanisms of gene expression are involved in the pathogenesis of this disorder. This article reviews the available data on epigenetic abnormalities found in patients with this disorder. The article also reviews the data on the use of epigenetic therapy in the treatment of obsessive-compulsive disorder, and epigenetic changes noted during psychotherapy of patients with this disorder. More detailed knowledge of the role of abnormal epigenetic mechanisms underlying obsessive-compulsive disorder could facilitate the development of new drugs for treating this disorder and the development of biomarkers for this disorder.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X347479241024120728
2025-02-12
2025-09-24

  • From This Site

    /content/journals/cn/10.2174/011570159X347479241024120728
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SteinD.J. LochnerC. Obsessive-compulsive and related disorders. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry; Sadock, B.J.; Sadock, V.A. RuizP. Philadelphia, PAWolters-Kluwer201717851798
     [Google Scholar]
  2. BrockH. RizviA. HanyM. Obsessive-compulsive disorder. StatPearls.Florida, USAStatPearls Publishing2024
     [Google Scholar]
  3. BelliaF. VismaraM. AnnunziE. CifaniC. BenattiB. Dell’OssoB. D’AddarioC. Genetic and epigenetic architecture of obsessive-compulsive disorder: In search of possible diagnostic and prognostic biomarkers.J. Psychiatr. Res.202113755457110.1016/j.jpsychires.2020.10.040 33213890
     [Google Scholar]
  4. MohammadiA.H. KarimianM. MirzaeiH. MilajerdiA. Epigenetic modifications and obsessive-compulsive disorder: What do we know?Brain Struct. Funct.202322851295130510.1007/s00429‑023‑02649‑4 37204485
     [Google Scholar]
  5. MurphyC.M. Writing an effective review article.J. Med. Toxicol.201282899010.1007/s13181‑012‑0234‑2 22552738
     [Google Scholar]
  6. CervinM. Obsessive-compulsive disorder.Psychiatr. Clin. North Am.202346111610.1016/j.psc.2022.10.006 36740346
     [Google Scholar]
  7. SteinD.J. CostaD.L.C. LochnerC. MiguelE.C. ReddyY.C.J. ShavittR.G. van den HeuvelO.A. SimpsonH.B. Obsessive-compulsive disorder.Nat. Rev. Dis. Primers2019515210.1038/s41572‑019‑0102‑3 31371720
     [Google Scholar]
  8. WittchenH.U. JacobiF. RehmJ. GustavssonA. SvenssonM. JönssonB. OlesenJ. AllgulanderC. AlonsoJ. FaravelliC. FratiglioniL. JennumP. LiebR. MaerckerA. van OsJ. PreisigM. Salvador-CarullaL. SimonR. SteinhausenH.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010.Eur. Neuropsychopharmacol.201121965567910.1016/j.euroneuro.2011.07.018 21896369
     [Google Scholar]
  9. ShephardE. BatistuzzoM.C. HoexterM.Q. SternE.R. ZuccoloP.F. OgawaC.Y. SilvaR.M. BrunoniA.R. CostaD.L. DorettoV. SaraivaL. CappiC. ShavittR.G. SimpsonH.B. van den HeuvelO.A. MiguelE.C. Neurocircuit models of obsessive-compulsive disorder: Limitations and future directions for research.Br. J. Psychiatry202244218720010.1590/1516‑4446‑2020‑1709 35617698
     [Google Scholar]
  10. ShephardE. SternE.R. van den HeuvelO.A. CostaD.L.C. BatistuzzoM.C. GodoyP.B.G. LopesA.C. BrunoniA.R. HoexterM.Q. ShavittR.G. ReddyY.C.J. LochnerC. SteinD.J. SimpsonH.B. MiguelE.C. Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder.Mol. Psychiatry20212694583460410.1038/s41380‑020‑01007‑8 33414496
     [Google Scholar]
  11. DoughertyD.D. BrennanB.P. StewartS.E. WilhelmS. WidgeA.S. RauchS.L. Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: A review.JAMA Psychiatry201875101081108710.1001/jamapsychiatry.2018.0930 30140845
     [Google Scholar]
  12. SoyakH.M. KarakükcüÇ. Investıgation of vitamin D levels in obsessive-compulsive disorder.Indian J. Psychiatry202264434935310.4103/indianjpsychiatry.indianjpsychiatry_26_22 36060722
     [Google Scholar]
  13. MarazzitiD. BarberiF.M. FontenelleL. BuccianelliB. CarboneM.G. ParraE. PalermoS. MassaL. TagliariniC. Della VecchiaA. MucciF. AroneA. Dell’OssoL. Decreased vitamin D levels in obsessive-compulsive disorder patients.CNS Spectr.202328560661310.1017/S1092852921000821 34551844
     [Google Scholar]
  14. ZaiG. BartaC. CathD. EapenV. GellerD. GrünblattE. New insights and perspectives on the genetics of obsessive-compulsive disorder.Psychiatr. Genet.201929514215110.1097/YPG.0000000000000230 31464995
     [Google Scholar]
  15. ViswanathB. PurtyA. NestadtG. SamuelsJ.F. Genetics of obsessive-compulsive disorder.Indian J. Psychiatry2019617Suppl. 13710.4103/psychiatry.IndianJPsychiatry_518_18 30745675
     [Google Scholar]
  16. QinH. SamuelsJ.F. WangY. ZhuY. GradosM.A. RiddleM.A. GreenbergB.D. KnowlesJ.A. FyerA.J. McCrackenJ.T. MurphyD.L. RasmussenS.A. CullenB.A. PiacentiniJ. GellerD. StewartS.E. PaulsD. BienvenuO.J. GoesF.S. MaherB. PulverA.E. ValleD. LangeC. MattheisenM. McLaughlinN.C. LiangK-Y. NurmiE.L. AsklandK.D. NestadtG. ShugartY.Y. Whole-genome association analysis of treatment response in obsessive-compulsive disorder.Mol. Psychiatry201621227027610.1038/mp.2015.32 25824302
     [Google Scholar]
  17. Mataix-ColsD. BomanM. MonzaniB. RückC. SerlachiusE. LångströmN. LichtensteinP. Population-based, multigenerational family clustering study of obsessive-compulsive disorder.JAMA Psychiatry201370770971710.1001/jamapsychiatry.2013.3 23699935
     [Google Scholar]
  18. MahjaniB. BeyK. BobergJ. BurtonC. Genetics of obsessive-compulsive disorder.Psychol. Med.202151132247225910.1017/S0033291721001744 34030745
     [Google Scholar]
  19. MonzaniB. RijsdijkF. HarrisJ. Mataix-ColsD. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders.JAMA Psychiatry201471218218910.1001/jamapsychiatry.2013.3524 24369376
     [Google Scholar]
  20. CathD.C. van GrootheestD.S. WillemsenG. van OppenP. BoomsmaD.I. Environmental factors in obsessive-compulsive behavior: Evidence from discordant and concordant monozygotic twins.Behav. Genet.200838210812010.1007/s10519‑007‑9185‑9 18188688
     [Google Scholar]
  21. KrackerI.A. AntônioC.C. do RosárioM.C. FontenelleL.F. ConstantinoM.E. ArzenoF.Y. Stressful life events and the clinical expression of obsessive-compulsive disorder (OCD): An exploratory study.J. Clin. Med.2020910337110.3390/jcm9103371 33096706
     [Google Scholar]
  22. SigraS. HesselmarkE. BejerotS. Treatment of PANDAS and PANS: A systematic review.Neurosci. Biobehav. Rev.201886516510.1016/j.neubiorev.2018.01.001 29309797
     [Google Scholar]
  23. AttwellsS. SetiawanE. WilsonA.A. RusjanP.M. MizrahiR. MilerL. XuC. RichterM.A. KahnA. KishS.J. HouleS. RavindranL. MeyerJ.H. Inflammation in the neurocircuitry of obsessive-compulsive disorder.JAMA Psychiatry201774883384010.1001/jamapsychiatry.2017.1567 28636705
     [Google Scholar]
  24. TollefsbolT.O. Epigenetics Overview. Handbook of Epigenetics: The New Molecular and Medical Genetics. TollefsbolT.O. San DiegoElsevier20233810.1016/B978‑0‑323‑91909‑8.00031‑1
     [Google Scholar]
  25. RodgerE.J. ChatterjeeA. The epigenomic basis of common diseases.Clin. Epigenetics201791510.1186/s13148‑017‑0313‑y 28149333
     [Google Scholar]
  26. FeinbergA.P. Epigenetics at the epicenter of modern medicine.JAMA2008299111345135010.1001/jama.299.11.1345 18349095
     [Google Scholar]
  27. FeinbergA.P. The key role of epigenetics in human disease prevention and mitigation.N. Engl. J. Med.2018378141323133410.1056/NEJMra1402513 29617578
     [Google Scholar]
  28. PeedicayilJ. GraysonD.R. An epigenetic basis for an omnigenic model of psychiatric disorders.J. Theor. Biol.2018443525510.1016/j.jtbi.2018.01.027 29378208
     [Google Scholar]
  29. PeedicayilJ. GraysonD.R. Some implications of an epigenetic-based omnigenic model of psychiatric disorders.J. Theor. Biol.2018452818410.1016/j.jtbi.2018.05.014 29775682
     [Google Scholar]
  30. PaulsD.L. The genetics of obsessive-compulsive disorder: a review.Dialogues Clin. Neurosci.201012214916310.31887/DCNS.2010.12.2/dpauls 20623920
     [Google Scholar]
  31. LewinA.B. PiacentiniJ. Obsessive compulsive disorder in childhood. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry; Sadock, B.J.; Sadock, V.A. RuizP. Philadelphia, PAWolters-Kluwer201736953703
     [Google Scholar]
  32. PeedicayilJ. Genome-environment interactions and psychiatric disorders.Biomedicines2023114120910.3390/biomedicines11041209 37189827
     [Google Scholar]
  33. MathisM.A. AlvarengaP. FunaroG. TorresanR.C. MoraesI. TorresA.R. ZilbermanM.L. HounieA.G. Gender differences in obsessive-compulsive disorder: A literature review.Rev. Bras. Psiquiatr.201133439039910.1590/S1516‑44462011000400014 22189930
     [Google Scholar]
  34. CherianA.V. NarayanaswamyJ.C. ViswanathB. GuruN. GeorgeC.M. BadaM.S. KandavelT. JanardhanR.Y.C. Gender differences in obsessive-compulsive disorder: Findings from a large Indian sample.Asian J. Psychiatr.20149172110.1016/j.ajp.2013.12.012 24813030
     [Google Scholar]
  35. MiglioreL. NicolìV. StoccoroA. Gender specific differences in disease susceptibility: The role of epigenetics.Biomedicines20219665210.3390/biomedicines9060652 34200989
     [Google Scholar]
  36. KhramtsovaE.A. HeldmanR. DerksE.M. YuD. DavisL.K. StrangerB.E. Sex differences in the genetic architecture of obsessive-compulsive disorder.Am. J. Med. Genet. B. Neuropsychiatr. Genet.2019180635136410.1002/ajmg.b.32687 30456828
     [Google Scholar]
  37. ParvopassuA. OggianoM. FestucciF. CurcioG. AllevaE. AdrianiW. Altering the development of the dopaminergic system through social play in rats: Implications for anxiety, depression, hyperactivity, and compulsivity.Neurosci. Lett.202176013609010.1016/j.neulet.2021.136090 34197903
     [Google Scholar]
  38. FestucciF. AnnunziE. PepeM. CurcioG. D’AddarioC. AdrianiW. Dopamine‐transporter heterozygous rats carrying maternal wild‐type allele are more vulnerable to the development of compulsive behavior.Synapse2022769-10e2224410.1002/syn.22244 35772468
     [Google Scholar]
  39. HillM.N. MackieK. Cannabinoids. Goodman & Gilman’s The Pharmacological Basis of Therapeutics; Brunton, L.L. KnollmanB.C. New YorkMcGraw-Hill2023505518
     [Google Scholar]
  40. HillM.N. HaneyM. HillardC.J. KarhsonD.S. VecchiarelliH.A. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.Psychol. Med.202353157006702410.1017/S0033291723002465 37671673
     [Google Scholar]
  41. NavarroD. GasparyanA. NavarreteF. TorregrosaA.B. RubioG. Marín-MayorM. AcostaG.B. Garcia-GutiérrezM.S. ManzanaresJ. Molecular alterations of the endocannabinoid system in psychiatric disorders.Int. J. Mol. Sci.2022239476410.3390/ijms23094764 35563156
     [Google Scholar]
  42. BelliaF. GirellaA. AnnunziE. BenattiB. VismaraM. PrioriA. FestucciF. FantiF. CompagnoneD. AdrianiW. Dell’OssoB. D’AddarioC. Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder.Transl. Psychiatry202414111810.1038/s41398‑024‑02829‑8 38409080
     [Google Scholar]
  43. HermeshH. WeizmanA. ShaharA. MunitzH. Vitamin B12 and folic acid serum levels in obsessive compulsive disorder.Acta Psychiatr. Scand.198878181010.1111/j.1600‑0447.1988.tb06294.x 3176999
     [Google Scholar]
  44. SharmaV. BiswasD. Cobalamin deficiency presenting as obsessive compulsive disorder: Case report.Gen. Hosp. Psychiatry2012345578.e7578.e810.1016/j.genhosppsych.2011.11.006 22227032
     [Google Scholar]
  45. EsnafoğluE. YamanE. Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder.Psychiatry Res.201725423223710.1016/j.psychres.2017.04.032 28477545
     [Google Scholar]
  46. TürksoyN. BiliciR. YalçınerA. OzdemirY.O. OrnekI. TufanA.E. KaraA. Vitamin B12, folate, and homocysteine levels in patients with obsessive-compulsive disorder.Neuropsychiatr. Dis. Treat.20141016711675 25228807
     [Google Scholar]
  47. BalandehE. KarimianM. BehjatiM. MohammadiA.H. Serum vitamins and homocysteine levels in obsessive-compulsive disorder: A systematic review and meta-analysis.Neuropsychobiology202180650251510.1159/000514075 33744893
     [Google Scholar]
  48. PeedicayilJ. Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders.J. Clin. Pharm. Ther.201237549950110.1111/j.1365‑2710.2012.01346.x 22449320
     [Google Scholar]
  49. PeedicayilJ. Nutritional effects on epigenetics in psychiatry. Epigenetics in Psychiatry; Peedicayil, J.; Grayson, D.R. AvramopoulosD. San DiegoElsevier202173775010.1016/B978‑0‑12‑823577‑5.00028‑3
     [Google Scholar]
  50. da SilvaV.C. de OliveiraA.C. D’AlmeidaV. Homocysteine and psychiatric disorders.J. Inborn Errors Metab. Screen.2017510.1177/2326409817701471
     [Google Scholar]
  51. NissenJ.B. HansenC.S. StarnawskaA. MattheisenM. BørglumA.D. ButtenschønH.N. HollegaardM. DNA methylation at the neonatal state and at the time of diagnosis: Preliminary support for an association with the estrogen receptor1, gamma-aminobutyric acid B receptor 1, and myelin oligodendrocyte glycoprotein in female adolescent patients with OCD.Front. Psychiatry201673510.3389/fpsyt.2016.00035 27047397
     [Google Scholar]
  52. YueW. ChengW. LiuZ. TangY. LuT. ZhangD. TangM. HuangY. Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients.Sci. Rep.2016613133310.1038/srep31333 27527274
     [Google Scholar]
  53. CappiC. DinizJ.B. RequenaG.L. LourençoT. LisboaB.C.G. BatistuzzoM.C. MarquesA.H. HoexterM.Q. PereiraC.A. MiguelE.C. BrentaniH. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder.BMC Neurosci.20161717910.1186/s12868‑016‑0313‑4 27903255
     [Google Scholar]
  54. GrünblattE. MarinovaZ. RothA. GardiniE. BallJ. GeisslerJ. WojdaczT.K. RomanosM. WalitzaS. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder.J. Psychiatr. Res.20189620921710.1016/j.jpsychires.2017.10.010 29102815
     [Google Scholar]
  55. D’AddarioC. BelliaF. BenattiB. GranciniB. VismaraM. PucciM. De CarloV. ViganòC. GalimbertiD. FenoglioC. ScarpiniE. MaccarroneM. Dell’OssoB. Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder.J. Psychiatr. Res.2019114172310.1016/j.jpsychires.2019.04.006 31004918
     [Google Scholar]
  56. ParkC.I. KimH.W. JeonS. KangJ.I. KimS.J. Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder.Clin. Epigenetics202012110110.1186/s13148‑020‑00890‑w 32631409
     [Google Scholar]
  57. GoodmanS.J. BurtonC.L. ButcherD.T. SiuM.T. LemireM. Chater-DiehlE. TurinskyA.L. BrudnoM. SoreniN. RosenbergD. FitzgeraldK.D. HannaG.L. AnagnostouE. ArnoldP.D. CrosbieJ. SchacharR. WeksbergR. Obsessive-compulsive disorder and attention-deficit/hyperactivity disorder: Distinct associations with DNA methylation and genetic variation.J. Neurodev. Disord.20201212310.1186/s11689‑020‑09324‑3 32799817
     [Google Scholar]
  58. de OliveiraK.C. CamiloC. GastaldiV.D. Sant’Anna FeltrinA. LisboaB.C.G. de Jesus Rodrigues de PaulaV. MorettoA.C. LaferB. HoexterM.Q. MiguelE.C. MaschiettoM. AkiyamaÉ.D. GrinbergL.T. LeiteR.E.P. SuemotoC.K. de Lucena Ferretti-RebustiniR.E. PasqualucciC.A. Jacob-FilhoW. BrentaniH. Brain areas involved with obsessive-compulsive disorder present different DNA methylation modulation.BMC Genom. Data20212214510.1186/s12863‑021‑00993‑0 34717534
     [Google Scholar]
  59. D’AddarioC. MacellaroM. BelliaF. BenattiB. AnnunziE. PalumboR. ContiD. FascianaF. VismaraM. VarinelliA. FerraraL. CelebreL. ViganòC. Dell’OssoB. In search for biomarkers in obsessive-compulsive disorder: New evidence on saliva as a practical source of DNA to assess epigenetic regulation.Curr. Med. Chem.202229365782579110.2174/0929867328666211208115536 34879796
     [Google Scholar]
  60. SchieleM.A. LipovsekJ. SchlosserP. SoutschekM. SchrattG. ZaudigM. BerberichG. KöttgenA. DomschkeK. Epigenome-wide DNA methylation in obsessive-compulsive disorder.Transl. Psychiatry202212122110.1038/s41398‑022‑01996‑w 35650177
     [Google Scholar]
  61. D’AddarioC. PucciM. BelliaF. GirellaA. SabatucciA. FantiF. VismaraM. BenattiB. FerraraL. FascianaF. CelebreL. ViganòC. ElliL. SergiM. MaccarroneM. BuzzelliV. TrezzaV. Dell’OssoB. Regulation of oxytocin receptor gene expression in obsessive-compulsive disorder: A possible role for the microbiota-host epigenetic axis.Clin. Epigenetics20221414710.1186/s13148‑022‑01264‑0 35361281
     [Google Scholar]
  62. GuoL. NiZ. WeiG. ChengW. HuangX. YueW. Epigenome-wide DNA methylation analysis of whole blood cells derived from patients with GAD and OCD in the Chinese Han population.Transl. Psychiatry202212146510.1038/s41398‑022‑02236‑x 36344488
     [Google Scholar]
  63. SeoJ.H. KimS.T. JeonS. KangJ.I. KimS.J. Sex-dependent association of DNA methylation of HPA axis-related gene FKBP5 with obsessive-compulsive disorder.Psychoneuroendocrinology202315810640410.1016/j.psyneuen.2023.106404 37769537
     [Google Scholar]
  64. HaoL.S. DuY. ChenL. JiaoY.G. ChengY. Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis.J. Psychiatr. Res.202215167668210.1016/j.jpsychires.2022.05.026 35667336
     [Google Scholar]
  65. DonduA. CaliskanM. Orenay-BoyaciogluS. Link between obsessive-compulsive disorder and polymorphisms in HDAC genes.Br. J. Psychiatry202244215616310.1590/1516‑4446‑2020‑1715 34730715
     [Google Scholar]
  66. LinG.N. SongW. WangW. WangP. YuH. CaiW. JiangX. HuangW. QianW. ChenY. ChenM. YuS. XuT. JiaoY. LiuQ. ZhangC. YiZ. FanQ. ChenJ. WangZ. De novo mutations identified by whole-genome sequencing implicate chromatin modifications in obsessive-compulsive disorder.Sci. Adv.202282eabi618010.1126/sciadv.abi6180 35020433
     [Google Scholar]
  67. AkbariM. HussenB.M. EslamiS. NeishabouriS.M. Ghafouri-FardS. Association between ANRIL polymorphisms and risk of obsessive-compulsive disorder.Heliyon202393e1408110.1016/j.heliyon.2023.e14081 36923904
     [Google Scholar]
  68. GhanbarzehiA. SepehrinezhadA. HashemiN. KarimiM. ShahbaziA. Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive-compulsive disorder by integrated bioinformatics analysis.BMC Psychiatry20232314010.1186/s12888‑023‑04543‑z 36641432
     [Google Scholar]
  69. PeedicayilJ. Pharmacoepigenetics and pharmacoepigenomics: An overview.Curr. Drug Discov. Technol.201916439239910.2174/1570163815666180419154633 29676232
     [Google Scholar]
  70. DarS.A. WaniR.A. HaqI. A comparative study of aripiprazole, olanzapine, and L-methylfolate augmentation in treatment resistant obsessive-compulsive disorder.Psychiatr. Q.20219241413142410.1007/s11126‑021‑09892‑0 33830427
     [Google Scholar]
  71. WangK. LiuH. HuQ. WangL. LiuJ. ZhengZ. ZhangW. RenJ. ZhuF. LiuG.H. Epigenetic regulation of aging: implications for interventions of aging and diseases.Signal Transduct. Target. Ther.20227137410.1038/s41392‑022‑01211‑8 36336680
     [Google Scholar]
  72. PaydaryK. AkamalooA. AhmadipourA. PishgarF. EmamzadehfardS. AkhondzadehS. N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.J. Clin. Pharm. Ther.201641221421910.1111/jcpt.12370 26931055
     [Google Scholar]
  73. AfsharH. RoohafzaH. Mohammad-BeigiH. HaghighiM. JahangardL. ShokouhP. SadeghiM. HafezianH. N-acetylcysteine add on treatment for refractory obsessive-compulsive disorder.J. Clin. Psychopharmacol.201232679780310.1097/JCP.0b013e318272677d 23131885
     [Google Scholar]
  74. SarrisJ. ByrneG. CastleD. BousmanC. OliverG. CribbL. Blair-WestS. BrakouliasV. CamfieldD. EeC. ChamoliS. BoschenM. DeanO.M. DowlingN. MenonR. MurphyJ. MetriN.J. NguyenT.P. WongA. JordanR. KaramacoskaD. RossellS.L. BerkM. NgC.H. N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.Prog. Neuropsychopharmacol. Biol. Psychiatry202211711055010.1016/j.pnpbp.2022.110550 35304155
     [Google Scholar]
  75. SarrisJ. RavindranA. YathamL.N. MarxW. RucklidgeJ. McIntyreR.S. AkhondzadehS. BenedettiF. CaneoC. CramerH. CribbL. de ManincorM. DeanO. DeslandesA.C. FreemanM.P. GangadharB. HarveyB.H. KasperS. LakeJ. LoprestiA. LuL. MetriN-J. MischoulonD. NgC.H. NishiD. RahimiR. Clinician guidelines for the treatment of psychiatric disorders with neutraceuticals and phytoceuticals: The world federation of societies for biological psychiatry (WFSBP) and Canadian Network for mood and anxiety treatments (CANMAT) taskforce.World J. Biol. Psychiatry20222342445510.1080/15622975.2021.2013041 35311615
     [Google Scholar]
  76. QuevedoY. BooijL. HerreraL. HernándezC. JiménezJ.P. Potential epigenetic mechanisms in psychotherapy: A pilot study on DNA methylation and mentalization change in borderline personality disorder.Front. Hum. Neurosci.20221695500510.3389/fnhum.2022.955005 36171872
     [Google Scholar]
  77. KandelE.R. A new intellectual framework for psychiatry.Am. J. Psychiatry1998155445746910.1176/ajp.155.4.457 9545989
     [Google Scholar]
  78. SchieleM.A. ThielC. DeckertJ. ZaudigM. BerberichG. DomschkeK. Monoamine oxidase Ahypomethylation in obsessive-compulsive disorder: Reversibility by successful psychotherapy?Int. J. Neuropsychopharmacol.202023531932310.1093/ijnp/pyaa016 32133483
     [Google Scholar]
  79. RodriguezN. Martinez-PinteñoA. BlázquezA. OrtizA.E. MorenoE. GassóP. LafuenteA. LazaroL. MasS. Integrative DNA methylation and gene expression analysis of cognitive behavioral therapy response in children and adolescents with obsessive-compulsive disorder; A pilot study.Pharm. Genomics Pers. Med.20211475776610.2147/PGPM.S313015 34234515
     [Google Scholar]
  80. SchieleM.A. ThielC. WeidnerM. EndresD. ZaudigM. BerberichG. DomschkeK. Serotonin transporter gene promoter hypomethylation in obsessive-compulsive disorder - Predictor of impaired response to exposure treatment?J. Psychiatr. Res.2021132182210.1016/j.jpsychires.2020.09.034 33035761
     [Google Scholar]
  81. BeyK. Campos-MartinR. KlawohnJ. ReuterB. GrützmannR. RieselA. WagnerM. RamirezA. KathmannN. Hypermethylation of the oxytocin receptor gene (OXTR) in obsessive-compulsive disorder: further evidence for a biomarker of disease and treatment response.Epigenetics202217664265210.1080/15592294.2021.1943864 34269138
     [Google Scholar]
  82. Campos-MartinR. BeyK. ElsnerB. ReuterB. KlawohnJ. PhilipsenA. KathmannN. WagnerM. RamirezA. Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response.Mol. Psychiatry202328104321433010.1038/s41380‑023‑02219‑4 37587247
     [Google Scholar]
  83. SyedS.A. ZannasA.S. Epigenetics in psychotherapy.Epigenetics in Psychiatry; Peedicayil, J.; Grayson, D.R. AvramopoulosD. San DiegoElsevier202170170910.1016/B978‑0‑12‑823577‑5.00015‑5
     [Google Scholar]
/content/journals/cn/10.2174/011570159X347479241024120728
Loading
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Obsessive-compulsive Disorder
Curr. Neuropharmacol. 23, 1484 (2025); https://doi.org/10.2174/011570159X347479241024120728
/content/journals/cn/10.2174/011570159X347479241024120728
/content/journals/cn/10.2174/011570159X347479241024120728
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Epigenetics; gene expression; obsessive-compulsive disorder; pathogenesis; quality of life; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test